Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality

Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan

(2012) Wuan-Szu Wang et al.   BMC PUBLIC HEALTH

Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study

(2012) Bozorgmanesh Mohammadreza et al.   Cardiovascular Diabetology

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II

(2012) Fereidoun Azizi et al.   Trials

Invited Commentary: The Importance of Prevalence in the Effectiveness of a (Bio)marker

(2011) A. Ghosh et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Diabetes and the risk of coronary heart disease in the general Japanese population: The Japan Public Health Center-based prospective (JPHC) study

(2011) Isao Saito et al.   ATHEROSCLEROSIS

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study

(2011) Sandra N Verhagen et al.   Cardiovascular Diabetology

Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study

(2011) Manuel A Gomez-Marcos et al.   Cardiovascular Diabetology

The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmö Preventive Project

(2011) Margret Leosdottir et al.   Cardiovascular Diabetology

Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey

(2011) Nancy Reynoso-Noverón et al.   Cardiovascular Diabetology

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

(2011) E. L. Lim et al.   DIABETOLOGIA

Cardiovascular Outcomes in Framingham Participants With Diabetes

(2011) Guanmin Chen et al.   HYPERTENSION

Estimation of the Population Attributable Fraction for Mortality in a Cohort Study Using a Piecewise Constant Hazards Model

(2010) M. A. Laaksonen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Reduction in Incidence of Type 2 Diabetes by Lifestyle Intervention in a Middle Eastern Community

(2010) Hadi Harati et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Counterpoint: Intensive Glucose Control and Mortality in ACCORD--Still Looking for Clues

(2010) M. C. Riddle   DIABETES CARE

Severe Hypoglycemia and Risks of Vascular Events and Death

(2010) Sophia Zoungas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Why should population attributable fractions be periodically recalculated?

(2010) María Grau et al.   PREVENTIVE MEDICINE

Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran

(2009) Hadi Harati et al.   BMC PUBLIC HEALTH

Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD

(2009) B. J. HOOGWERF   CLEVELAND CLINIC JOURNAL OF MEDICINE

High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study

(2008) Farzad Hadaegh et al.   BMC PUBLIC HEALTH

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

(2008) Jay S. Skyler et al.   CIRCULATION

Sustained Efficacy and Reduced Hypoglycemia during One Year of Treatment with Vildagliptin Added to Insulin in Patients with Type 2 Diabetes Mellitus

(2008) V. Fonseca et al.   HORMONE AND METABOLIC RESEARCH

Attributable fractions with survival data

(2007) Sven Ove Samuelsen et al.   STATISTICS IN MEDICINE